MARKET

RXDX

RXDX

Prometheus Biosciences, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

27.76
-0.93
-3.24%
After Hours: 27.21 -0.55 -1.98% 16:35 04/22 EDT
OPEN
28.59
PREV CLOSE
28.69
HIGH
30.62
LOW
27.17
VOLUME
130.17K
TURNOVER
--
52 WEEK HIGH
30.62
52 WEEK LOW
16.11
MARKET CAP
1.08B
P/E (TTM)
-13.3629
1D
5D
1M
3M
1Y
5Y
Crohn's Disease Diagnostics and Therapeutics Market 2020 Industry Size, Growth, Manufacturers, Segments and 2025 Forecast Report
Comserve · 13h ago
Global Proleukin Market 2020 - 2026 Business Statistics of Report that Emphasizes the impact of COVID-19
Apr 19, 2021 (CDN Newswire via Comtex) -- Global Proleukin Market Growth 2020-2026 released by MarketandResearch.biz is a proficient report which offers...
CDN Newswire · 3d ago
Global Aldesleukin Market 2020 Research during the Ongoing COVID-19 Pandemic, Growth and Research Methodology by Forecast to 2026
CDN Newswire · 3d ago
Global Acral Lentiginous Melanoma Treatment Market 2020 to 2026 Product, Distribution Channel, Region, Forecast and Opportunities during Ongoing COVID-19 Pandemic
Apr 19, 2021 (CDN Newswire via Comtex) -- Global Acral Lentiginous Melanoma Treatment Market Growth (Status and Outlook) 2020-2026 by MarketandResearch.biz...
CDN Newswire · 3d ago
Global Acral Lentiginous Melanoma Market 2020 - 2026 Research Report Segment Outlook, Growth Potentials and Analysis of COVID-19 Worldwide Outbreak
Apr 19, 2021 (CDN Newswire via Comtex) -- Global Acral Lentiginous Melanoma Market Growth 2020-2026 is a resource, which provides current as well as upcoming...
CDN Newswire · 3d ago
Global Acral Lentiginous Melanoma Drugs Market 2020 Growth Statistics, New Opportunities, Competitive Outlook and COVID-19 Analysis 2026
Apr 19, 2021 (CDN Newswire via Comtex) -- The recently uploaded report titled Global Acral Lentiginous Melanoma Drugs Market Growth 2020-2026 delivers...
CDN Newswire · 3d ago
Proleukin Market Classification, Opportunities, Types and Applications, Status and Forecast 2021 to 2028 By Ameco Research
pune, India, Sun, 18 Apr 2021 22:30:35 / Comserve Inc. / -- The global Proleukin market is thoroughly, accurately, and comprehensively assessed in the report...
Comserve · 3d ago
Acral Lentiginous Melanoma Market Size, Share, Growth,Trends, COVID-19 Analysis and Forecast 2021-2028
pune, India, Sun, 18 Apr 2021 22:25:40 / Comserve Inc. / -- The global Acral Lentiginous Melanoma market is thoroughly, accurately, and comprehensively...
Comserve · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RXDX. Analyze the recent business situations of Prometheus Biosciences, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RXDX stock price target is 32.25 with a high estimate of 40.00 and a low estimate of 25.00.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About RXDX
Prometheus Biosciences, Inc. is a biotechnology company. The Company is engaged in the discovery, development, and commercialization of therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD). Its precision medicine platform Prometheus360, which includes gastrointestinal (GI) bioinformatics databases, to identify therapeutic targets and develop therapeutic candidates to engage the targets. The Company's product pipeline includes PRA023, PR600, PR300, PR1800 and PR2100. Its lead product candidate PRA023, is an IgG1 humanized monoclonal antibody (mAb) designed to target both inflammation and fibrosis associated with IBD. It has focused on developing PRA023 for the treatment of UC and Crohn’s disease (CD).

Webull offers kinds of Prometheus Biosciences Inc stock information, including NASDAQ:RXDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RXDX stock methods without spending real money on the virtual paper trading platform.